Byetta and Pancreatitis: What You Should Know
The injected Type 2 diabetes drug exenatide (brand name Byetta) has been in the news this week because of safety concerns. The U.S. Food and Drug Administration (FDA) announced on August 18 that six cases of severe pancreatitis have been reported in people taking Byetta since October 2007. Read More “Byetta and Pancreatitis: What You Should Know”